AI IntelligenceAug 24, 2026AI Intelligence
Article
The FDA cleared C2N Diagnostics' PrecivityAD2 blood test, developed from Washington University technology, to aid Alzheimer's...
Diagnosis by detecting amyloid plaques. This marks a step toward accessible early detection.
Data Cube AI EditorialSource: Hacker News
01
Source Brief
The FDA cleared C2N Diagnostics' PrecivityAD2 blood test, developed from Washington University technology, to aid Alzheimer's diagnosis by detecting amyloid plaques. This marks a step toward accessible early detection.
02